CLIP Identifies Nova-Regulated RNA Networks in the Brain

Nova proteins are neuron-specific antigens targeted in paraneoplastic opsoclonus myoclonus ataxia (POMA), an autoimmune neurologic disease characterized by abnormal motor inhibition.Nova proteins regulate neuronal pre-messenger RNA splicing by directly binding to RNA.To identify Nova RNA targets, we developed a method to purify protein-RNA complexes from mouse brain with the use of ultraviolet cross-linking and immunoprecipitation (CLIP).Thirty-four transcripts were identified multiple times by Nova CLIP.Three-quarters of these encode proteins that function at the neuronal synapse, and one-third are involved in neuronal inhibition.Splicing targets confirmed in Nova–/– mice include c-Jun N-terminal kinase 2, neogenin, and gephyrin; the latter encodes a protein that clusters inhibitory γ-aminobutyric acid and glycine receptors, two previously identified Nova splicing targets.Thus, CLIP reveals that Nova coordinately regulates a biologically coherent set of RNAs encoding multiple components of the inhibitory synapse, an observation that may relate to the cause of abnormal motor inhibition in POMA.

[1]  D. Black.  Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.

[2]  R. Darnell,et al.  Nova Regulates GABAA Receptor γ2 Alternative Splicing via a Distal Downstream UCAU-Rich Intronic Splicing Enhancer , 2003, Molecular and Cellular Biology.

[3]  I. Weiler,et al.  RNA Cargoes Associating with FMRP Reveal Deficits in Cellular Functioning in Fmr1 Null Mice , 2003, Neuron.

[4]  J. Darnell,et al.  Microarray Identification of FMRP-Associated Brain mRNAs and Altered mRNA Translational Profiles in Fragile X Syndrome , 2001, Cell.

[5]  J. Darnell,et al.  Fragile X Mental Retardation Protein Targets G Quartet mRNAs Important for Neuronal Function , 2001, Cell.

[6]  M. Hengartner,et al.  jkk‐1 and mek‐1 regulate body movement coordination and response to heavy metals through jnk‐1 in Caenorhabditis elegans , 2001, The EMBO journal.

[7]  D. Ji,et al.  Timing and Location of Nicotinic Activity Enhances or Depresses Hippocampal Synaptic Plasticity , 2001, Neuron.

[8]  H. Lerche,et al.  Ion channels and epilepsy. , 2001, American journal of medical genetics.

[9]  R. Darnell,et al.  Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration. , 2001, Annual review of neuroscience.

[10]  Alexandros D. Polydorides,et al.  The splice of life: Alternative splicing and neurological disease , 2001, Nature Reviews Neuroscience.

[11]  H. Zoghbi,et al.  The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract. , 2001, Human molecular genetics.

[12]  S. Tenenbaum,et al.  Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  E. Borrelli,et al.  Neuroprotective Role of Dopamine Against Hippocampal Cell Death , 2000, The Journal of Neuroscience.

[14]  J. Kirsch,et al.  Diversity and phylogeny of gephyrin: tissue-specific splice variants, gene structure, and sequence similarities to molybdenum cofactor-synthesizing and cytoskeleton-associated proteins. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Darnell,et al.  A brain-enriched polypyrimidine tract-binding protein antagonizes the ability of Nova to regulate neuron-specific alternative splicing. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S K Burley,et al.  The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C. Becker,et al.  Autoimmunity to Gephyrin in Stiff-Man Syndrome , 2000, Neuron.

[18]  R. Darnell,et al.  Sequence-Specific RNA Binding by a Nova KH Domain Implications for Paraneoplastic Disease and the Fragile X Syndrome , 2000, Cell.

[19]  Robert B Darnell,et al.  Nova-1 Regulates Neuron-Specific Alternative Splicing and Is Essential for Neuronal Viability , 2000, Neuron.

[20]  J. Brandstätter,et al.  Loss of Postsynaptic GABAA Receptor Clustering in Gephyrin-Deficient Mice , 1999, The Journal of Neuroscience.

[21]  G. Feng,et al.  Dual requirement for gephyrin in glycine receptor clustering and molybdoenzyme activity. , 1998, Science.

[22]  R. Darnell,et al.  The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Christian Lüscher,et al.  G Protein-Coupled Inwardly Rectifying K+ Channels (GIRKs) Mediate Postsynaptic but Not Presynaptic Transmitter Actions in Hippocampal Neurons , 1997, Neuron.

[24]  H. Cooper,et al.  Mouse Neogenin, a DCC-like molecule, has four splice variants and is expressed widely in the adult mouse and during embryogenesis , 1997, Oncogene.

[25]  R. Darnell,et al.  The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo , 1997, Molecular and cellular biology.

[26]  M. Masu,et al.  Deleted in Colorectal Cancer (DCC) Encodes a Netrin Receptor , 1996, Cell.

[27]  H. K. Sluss,et al.  Selective interaction of JNK protein kinase isoforms with transcription factors. , 1996, The EMBO journal.

[28]  E. Casanova,et al.  Identification of four splice variants of the mouse stress-activated protein kinase JNK/SAPK alpha-isoform. , 1996, Neuroreport.

[29]  E. Tan,et al.  Autoantibodies in the diagnosis of systemicrheumatic diseases , 1995 .

[30]  J. Keene,et al.  Selection of a subset of mRNAs from combinatorial 3' untranslated region libraries using neuronal RNA-binding protein Hel-N1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Steitz,et al.  Snurps and scyrps , 1981, Cell.

[32]  J. Steitz,et al.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. , 1979, Proceedings of the National Academy of Sciences of the United States of America.